Delivery Order SPE2DX15D1906-SPE2DX24FC8FB
Award Date
8/27/24
Potential Completion Date
8/28/24
Potential Value
$2.8K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,049.14 firm-fixed-price contract is for the delivery of 4,560,272,823 units of 20 mg Atorvastatin tablets for medical use. The contract has an ultimate completion date of March 16, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,105.38, is for the delivery of Atorvastatin 40 mg tablets (1,000 per bottle) and has a completion date of June 14, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the delivery of 1,000 units of Atorvastatin 40 mg tablets, with a ceiling value of $1,242.36. The contract has a firm fixed price pricing type and does not utilize any set-aside designations. The ultimate completion date for this delivery order is September 11, 2024. Amerisourcebergen is a major supplier of pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Atorvastatin 40 mg tablets, a cardiovascular medication, with a ceiling value of $3,304.55 and a performance period through April 2024. The contract is a delivery order, with a firm fixed price, and was not set aside for any specific business category. Amerisourcebergen Drug Corp is a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,429.37 order is for the delivery of 1,000 units of Atorvastatin 40 mg tablets, a generic pharmaceutical product. No set-aside designation was used for this award. Amerisourcebergen Drug Corp has a history of providing pharmaceutical products and...
The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at one hundred sixty-seven thousand, eight hundred eighty-eight dollars for the supply of five hundred tablets of the generic cholesterol medication atorvastatin. To be performed over a one day period in Conshohocken, Pennsylvania, this order is likely placed against DLA's Pharmaceutical Prime Vendor contract, a multiple award indefinite delivery/indefinite quantity vehicle used by...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $28,000 to Amerisourcebergen Drug Corporation. The order is for 500 tablets of the generic cholesterol medication atorvastatin 20 mg. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in late August 2023. As a leading provider of pharmaceuticals and medical supplies to the Department of Defense, this order for a commonly prescribed drug...
The Defense Logistics Agency awarded a $6,220 delivery order to Amerisourcebergen Drug Corporation for 80mg atorvastatin tablets. Under this firm fixed price contract, Amerisourcebergen will supply 90 tablets of the generic cholesterol medication to a location in Conshohocken, Pennsylvania by July 25, 2023 to support the Department of Defense's medical supply needs. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply chain for the...
This federal contract award, valued at $3,223.60, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of 4,562,417,388 units of Atorvastatin 40 mg tablets, with a period of performance through October 10, 2023. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $983 to Amerisourcebergen Drug Corporation for the supply of 500 tablets of the cholesterol-lowering drug atorvastatin. As the prime contractor, Amerisourcebergen will deliver the generic pharmaceutical to a Defense Logistics Agency facility located in Conshohocken, Pennsylvania between September 21-22, 2023. No subcontractors or set-aside designations were indicated. The order is likely placed against...